{"id":"W2038780142","doi":"10.1016/j.ejca.2015.02.005","title":"Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Minimal clinically important difference; Quality of life (healthcare); Lapatinib; Placebo; Breast cancer; Discontinuation; SF-36; Randomized controlled trial; Internal medicine; Physical therapy; Adverse effect; Cancer; Health related quality of life; Disease; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006976699,0.001138254,0.00235869,0.000284156,0.0004625674,0.0006771684,0.0005053474,0.00151164,0.005452291],"category_scores_gemma":[0.001252111,0.00054947,0.001682156,0.0002822132,0.0008295722,0.0006135234,0.0005083125,0.00241723,0.0005797545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006126824,"about_ca_system_score_gemma":0.000756762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001883819,"about_ca_topic_score_gemma":0.003064094,"domain_scores_codex":[0.9996458,0.000161243,0.00002303051,0.00006021644,0.00002238451,0.00008731154],"domain_scores_gemma":[0.9995849,0.00008439572,0.00008816702,0.00003376909,0.00002997622,0.0001787402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9867666,0.004457327,0.0009464551,0.0002612157,0.000384108,0.00002245345,0.00002643411,0.00010876,0.001534718,0.00002850312,0.0002431429,0.005220193],"study_design_scores_gemma":[0.884594,0.1047852,0.008444895,0.00003534559,0.0008447646,0.0000228722,0.00004223936,0.0002246301,0.0003626011,0.00008950723,0.0005385508,0.00001527776],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944336,0.002235593,0.0001407395,0.0004072239,0.0003229664,0.0008104896,0.0006055046,0.00002952643,0.001014437],"genre_scores_gemma":[0.994086,0.001000009,0.000276644,0.0005358543,0.0002477506,0.00114317,0.0006085984,0.000005752227,0.002096136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005452291,"threshold_uncertainty_score":0.0182398,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09232333326504484,"score_gpt":0.4008121555903717,"score_spread":0.3084888223253269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}